Sat, Apr 19, 2014, 1:14 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • billyteex1 billyteex1 Sep 11, 2007 4:33 PM Flag

    Nothing new

    No earth shattering news. The news that PHRM expressed that trhey do not see any gain in projections for 2007. Manuso stated that S110 will benefit Dacogan later. Stated Md's probably would not shift because of a paper about survival benefit. Looking like Dacogen will continue to grow in 2007. Also if you look at IMS July number of 12.3M, this suggests that Dacogent most likely will beat the 35M number hands down and may test 37-38M. Just look closely and compare where they're in relation to last quarter.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Should of scratched Manuso from my line up. No bad news and Dacogen looks like the superior compound. Does anyone have clarity on milestones that MGI still owes. Manuso stated 24M outstanding. These are triggered on EU and Japan approvals. Just wonder if that'sdoesn't include the 23.5M JNJ would own. I know reading the 10-K, there were amounts owned by MGI and of course we know the JNJ deal has 50% of milestones going to Supg.

8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Rayonier Inc.
NYSEThu, Apr 17, 2014 4:03 PM EDT